ID
41461
Description
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 The Vital Signs Form has to be filled in each time they are measured according to the Protocol: Record at baseline and at least once per day at approximately the same time during Argatroban infusion.
Lien
https://clinicaltrials.gov/ct2/show/NCT00039858
Mots-clés
Versions (1)
- 18/10/2020 18/10/2020 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
18 octobre 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Vital Signs
- StudyEvent: ODM
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
(dd-mmm-yyyy)
Type de données
date
Alias
- UMLS CUI [1]
- C2826644
Description
(0000-2359)
Type de données
time
Alias
- UMLS CUI [1]
- C2826762
Description
Systolic blood pressure
Type de données
integer
Alias
- UMLS CUI [1]
- C0871470
Description
Diastolic blood pressure
Type de données
integer
Alias
- UMLS CUI [1]
- C0428883
Description
Heart rate
Type de données
integer
Unités de mesure
- bpm
Alias
- UMLS CUI [1]
- C0018810
Description
Respiratory rate
Type de données
integer
Unités de mesure
- breaths/min
Alias
- UMLS CUI [1]
- C0231832
Description
Body temperature
Type de données
float
Alias
- UMLS CUI [1]
- C0005903
Description
Temperature - unit
Type de données
text
Alias
- UMLS CUI [1,1]
- C0005903
- UMLS CUI [1,2]
- C1519795
Similar models
Vital Signs
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
Aucun commentaire